Clinical Trial Update: LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for LUT014 evaluating its use in radiation-induced dermatitis in breast cancer patients across Phase 1 and Phase 2, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation Dermatitis

Drugs mentioned

• LUT014

Snippet

Sponsor: Lutris Pharma Ltd. | Conditions: Radiation Dermatitis | Phase 1, Phase 2 | Status: COMPLETED